Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Blinded, Parallel Group, Multi-center Dose-finding Study, to Assess the Efficacy, Safety and Tolerability of Different Doses of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection
Brief Summary: The purpose of this study was to support the selection of a safe and tolerable tobramycin inhalation powder (TIP) dose, and regimen that exhibits effective bacterial reduction of P. aeruginosa in non-cystic fibrosis bronchiectasis (BE) patients with P. aeruginosa colonization.


Options:
A: Arm Label: AZLI-AZLI; Type: EXPERIMENTAL; Interventions: Drug: AZLI | Arm Label: Placebo-AZLI; Type: PLACEBO_COMPARATOR; Interventions: Drug: AZLI, Drug: Placebo | Intervention Type: DRUG; Name: AZLI; Assigned to Arm(s): AZLI-AZLI, Placebo-AZLI | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo-AZLI
B: Arm Label: Cohort A (3 capsules o.d.): TIP; Type: EXPERIMENTAL; Interventions: Drug: TIP | Arm Label: Cohort A (3 capsules o.d.): TIP/PBO; Type: EXPERIMENTAL; Interventions: Drug: TIP and placebo | Arm Label: Cohort A (3 capsules o.d.): PBO; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Cohort B (5 capsules o.d.): TIP; Type: EXPERIMENTAL; Interventions: Drug: TIP | Arm Label: Cohort B (5 capsules o.d.): TIP/PBO; Type: EXPERIMENTAL; Interventions: Drug: TIP and placebo | Arm Label: Cohort B (5 capsules o.d.): PBO; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Cohort C (4 capsules b.i.d.): TIP; Type: EXPERIMENTAL; Interventions: Drug: TIP | Arm Label: Cohort C (4 capsules b.i.d.): TIP/PBO; Type: EXPERIMENTAL; Interventions: Drug: TIP and placebo | Arm Label: Cohort C (4 capsules b.i.d.): PBO; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: TIP; Assigned to Arm(s): Cohort A (3 capsules o.d.): TIP, Cohort B (5 capsules o.d.): TIP, Cohort C (4 capsules b.i.d.): TIP | Intervention Type: DRUG; Name: TIP and placebo; Assigned to Arm(s): Cohort A (3 capsules o.d.): TIP/PBO, Cohort B (5 capsules o.d.): TIP/PBO, Cohort C (4 capsules b.i.d.): TIP/PBO | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Cohort A (3 capsules o.d.): PBO, Cohort B (5 capsules o.d.): PBO, Cohort C (4 capsules b.i.d.): PBO
C: Arm Label: Ciprofloxacin dispersion for inhalation; Type: EXPERIMENTAL; Interventions: Drug: Ciprofloxacin dispersion for inhalation | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ciprofloxacin dispersion for inhalation; Assigned to Arm(s): Ciprofloxacin dispersion for inhalation | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Ciprofloxacin DPI 28 Days on/off (Cipro 28); Type: EXPERIMENTAL; Interventions: Drug: Ciprofloxacin DPI (BAYQ3939) | Arm Label: Ciprofloxacin DPI 14 Days on/off (Cipro 14); Type: EXPERIMENTAL; Interventions: Drug: Ciprofloxacin DPI (BAYQ3939) | Arm Label: Placebo 28 Days on/off (Placebo 28); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Placebo 14 Days on/off (Placebo 14); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ciprofloxacin DPI (BAYQ3939); Assigned to Arm(s): Ciprofloxacin DPI 14 Days on/off (Cipro 14), Ciprofloxacin DPI 28 Days on/off (Cipro 28) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo 14 Days on/off (Placebo 14), Placebo 28 Days on/off (Placebo 28)

Answer: B